Importance of light in the treatment of vitiligo with JAK-inhibitors

Deep JoshipuraDepartment of Dermatology, New York Medical College, Valhalla, NY, USA

http://orcid.org/0000-0001-7579-4253

Natalia PlotnikovaDepartment of Dermatology, New York Medical College, Valhalla, NY, USA

Ari GoldminzDepartment of Dermatology, New York Medical College, Valhalla, NY, USA

Sandhya DeverapalliDepartment of Dermatology, New York Medical College, Valhalla, NY, USA

Yana TurkowskiDepartment of Dermatology, New York Medical College, Valhalla, NY, USA

Alice GottliebDepartment of Dermatology, Tufts Medical Center, Boston, MA, USA

David RosmarinDepartment of Dermatology, New York Medical College, Valhalla, NY, USACorrespondence[email protected]

show all

References

Hercogová J, Buggiani G, Prignano F, Lotti T. A rational approach to the treatment of vitiligo and other hypomelanoses. Dermatol Clin. 2007;25:383–92.
PubMed Web of Science ®Google Scholar
Teulings HE, Overkamp M, Ceylan E, et al. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Br J Dermatol. 2013;168:162–71.
PubMed Web of Science ®Google Scholar
Rashighi M, Agarwal P, Richmond JM, et al. CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med. 2014;6:223ra23.
PubMed Web of Science ®Google Scholar
Craiglow BG, King BA. Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy. JAMA Dermatol. 2015;151:1110–12.
PubMed Web of Science ®Google Scholar
Harris JE, Rashighi M, Nguyen N, et al. Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). J Am Acad Dermatol. 2016;74:370–1.
PubMed Web of Science ®Google Scholar
Rothstein B, Joshipura D, Saraiya A, et al. Treatment of vitiligo with topical janus kinase inhibitor ruxolitinib. J Am Acad Dermatol. 2017;76:1054–60.e1.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Importance of light in the treatment of vitiligo with JAK-inhibitors

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Importance of light in the treatment of vitiligo with JAK-inhibitors

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date